🔗 Visit the ClinicalTrials.gov page for NCT01556009
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. | Nat Rev Clin Oncol | 2015 | 2.02 |
| 2 | Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors. | Cancers (Basel) | 2016 | 0.91 |
| 3 | The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome. | JAMA Dermatol | 2014 | 0.89 |
| 4 | Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors. | Biologics | 2015 | 0.85 |
| 5 | Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyond. | Dermatol Ther (Heidelb) | 2013 | 0.76 |
| 6 | Investigational agents in metastatic basal cell carcinoma: focus on vismodegib. | J Exp Pharmacol | 2012 | 0.75 |